Tag: Viruses

Findings seen in phase 3 trial of adults aged 60 years and older receiving a single intramuscular injection of RSVpreF vaccine

14 cases identified in Equatorial Guinea, 10 of which were fatal; five people have died in eight confirmed cases in Tanzania

Phase 3 trial shows the vaccine is effective against medically attended severe RSV-associated lower respiratory tract illness in infants

However, evidence shows the 2022 to 2023 season is a return toward prepandemic seasonality

Researchers say their findings highlights the risks of referring to TikTok or social media as health information source

Data were synthesized from animal models, medical countermeasure use for human cases of related OPXV, input from experts, experience during consultations

High vaccine efficacy seen against RSV A and B subtypes, across age groups among those aged 60 years and older, and for those with coexisting conditions

Vaccination results in lower RSV-mediated lower respiratory tract disease meeting one of three definitions

From October 2020 to February 2021, rhinoviruses and/or enteroviruses detected at same or higher odds than in prepandemic months

Primary series coverage by end of 2022 was below the 100 percent target set for at-risk populations